Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in PerinatologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The future of in utero gene therapy.Mol Diagn Ther. 2020; 24: 135-142
- The diagnosis of sex before birth using cells from the amniotic fluid (a preliminary report).Bull Res Counc Isr. 1955; 5B: 137-138
- Prenatal genetic testing options.Pediatr Clin North Am. 2019; 66: 281-293
- Amniocentesis and chorionic villus sampling for prenatal diagnosis.Cochrane Database Syst Rev. 2017; 9: CD003252
- Next-generation sequencing and the impact on prenatal diagnosis.Expert Rev Mol Diagn. 2018; 18: 689-699
- Presence of fetal DNA in maternal plasma and serum.Lancet (London, England). 1997; 350: 485-487
- Prenatal diagnosis: screening and diagnostic tools.Obstet Gynecol Clin North Am. 2017; 44: 245-256
- Non-invasive prenatal diagnosis and screening for monogenic disorders.Eur J Obstet Gynecol Reprod Biol. 2020; 253: 320-327
- Fetal stem cell and gene therapy.Semin Fetal Neonatal Med. 2017; 22: 410-414
- The developmental stage determines the distribution and duration of gene expression after early intra-amniotic gene transfer using lentiviral vectors.Gene Ther. 2009; 17: 61-71
- Perinatal systemic gene delivery using adeno-associated viral vectors.Front Mol Neurosci. 2014; 0: 89
- In utero gene therapy: current challenges and perspectives.Mol Ther. 2005; 11: 661-676
- Fetal gene therapy for neurodegenerative disease of infants.Nat Med. 2018; 24: 1317-1323
- Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow.N Engl J Med. 1996; 335: 1806-1810
- In utero bone marrow transplantation induces donor-specific tolerance by a combination of clonal deletion and clonal anergy.J Pediatr Surg. 1999; 34: 726-729
- High-level allogeneic chimerism achieved by prenatal tolerance induction and postnatal nonmyeloablative bone marrow transplantation.Blood. 2002; 100: 2225-2234
- Transplantation of fetal hematopoietic stem cells in utero: the creation of hematopoietic chimeras.Science. 1986 Aug 15; 233 (PMID: 2874611): 776-778https://doi.org/10.1126/science.2874611
- Adeno-associated virus antibody profiles in newborns, children, and adolescents.Clin Vaccin Immunol. 2011; 18: 1586-1588
- Identification of preexisting adaptive immunity to Cas9 proteins in humans.Nat Med. 2019; 25: 249-254
- Placental transport of immunoglobulin G.Vaccine. 2003; 21: 3365-3369
- Pre-clinical assessment of immune responses to adeno-associated virus (AAV) vectors.Front Immunol. 2014; 5: 28
- Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial.Hum Gene Ther. 2007; 18: 726-732
- Induction of stable prenatal tolerance to beta-galactosidase by in utero gene transfer into preimmune sheep fetuses.Blood. 2001; 97: 3417-3423
- Induction of immune tolerance to foreign protein via adeno-associated viral vector gene transfer in mid-gestation fetal sheep.PLoS One. 2017; 12: e0171132
- Persistent expression of hF.IX after tolerance induction by in utero or neonatal administration of AAV-1-F.IX in hemophilia B mice.Mol Ther. 2007; 15: 1677-1685
- Fetal gene therapy using a single injection of recombinant AAV9 rescued SMA phenotype in mice.Mol Ther. 2019; 27: 2123-2133
- Gene editing on center stage.Trends Genet. 2018; 34: 600-611
- Genome editing. The new frontier of genome engineering with CRISPR-Cas9.Science. 2014; 346: 1258096
- Genome-wide target specificities of CRISPR RNA-guided programmable deaminases.Nat Biotechnol. 2017; 35: 475-480
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage.Nature. 2017; 551
- Search-and-replace genome editing without double-strand breaks or donor DNA.Nature. 2019; 576: 149-157
- In utero gene editing for monogenic lung disease.Sci Transl Med. 2019 Apr 17; 11 (PMID: 30996081; PMCID: PMC6822403): eaav8375https://doi.org/10.1126/scitranslmed.aav8375
- In Utero CRISPR-mediated therapeutic editing of metabolic genes.Nat Med. 2018; 24: 1513-1518
- In utero adenine base editing corrects multi-organ pathology in a lethal lysosomal storage disease.Nat Commun. 2021; 12: 1-16
- Viral vector platforms within the gene therapy landscape.Signal Transduction Targeted Ther. 2021; 6: 1-24
- Progress in developing cationic vectors for non-viral systemic gene therapy against cancer.Biomaterials. 2008; 29: 3477-3496
- Non-viral vectors in gene therapy: recent development, challenges, and prospects.AAPS J. 2021; 23: 78
- Physicochemical properties of cationic nanoemulsions and liposomes obtained by microfluidization complexed with a single plasmid or along with an oligonucleotide: implications for CRISPR/Cas technology.J Colloid Interface Sci. 2018; 530: 243-255
- In Utero nanoparticle delivery for site-specific genome editing.Nat Commun. 2018; 9: 1-11
- Intrauterine fetal gene therapy: is that the future and is that future now?.Cureus. 2022; 14: e22521
- Widespread labeling and genomic editing of the fetal central nervous system by in utero CRISPR AAV9-PHP.eB administration.Development. 2021; 148: dev195586
- Enzyme replacement therapy – a brief history.in: Atul Mehta Michael Beck Gere Sunder-Plassmann Fabry disease: perspectives from 5 years of FOS. Oxford PharmaGenesis, Oxford2006
- Enzyme replacement therapy and beyond-in memoriam Roscoe O. Brady, M.D. (1923-2016).J Inherit Metab Dis. 2017; 40: 343-356
- In utero enzyme replacement therapy for lysosomal storage diseases - identifier: NCT04532047 national library of medicine (US).(Available at:) (Accessed June 3, 2022)
- Intraamniotic administrations of ER004 to male subjects with X-linked hypohidrotic ectodermal dysplasia- identifier: NCT04980638.National Library of Medicine (US), 2021 (Available at:) (Accessed June 3, 2022)
- Prenatal correction of X-Linked hypohidrotic ectodermal dysplasia.. 2018; 378: 1604-1610https://doi.org/10.1056/NEJMoa1714322
- In utero hematopoietic cell transplantation: induction of donor specific immune tolerance and postnatal transplants.Front Pharmacol. 2014; 5: 251
- Severe combined immunodeficiencies.Immunodefic Rev. 1992; 3: 83-100
- In utero stem cell transplantation in patients with alpha thalassemia major: interim results of a phase 1 clinical trial | request PDF.Blood. 2022; 136: 1
- Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation.Lancet. 1981; 2: 709-712
- Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts.Science. 1968; 162: 570-572
- Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan.Mol Genet Metab. 2012; 107: 513-520
- Osteogenesis imperfecta.3rd edition. Elsevier, Amsterdam2008
- Boost brittle bones before birth - identifier: NCT03706482 national library of medicine (US).(Available at:) (Accessed June 3, 2022)
- Cellular therapy for in utero repair of myelomeningocele - the CuRe trial - identifier: NCT04652908 national library of medicine (US).(Available at:) (Accessed June 3, 2022)
- Placental mesenchymal stromal cells rescue ambulation in ovine myelomeningocele.Stem Cells Translational Med. 2015; 4: 659-669
- In utero gene therapy consensus statement from the IFeTIS.Mol Ther. 2019; 27: 705-707
- Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures.Ultrasound Obstet Gynecol. 2017; 50: 180-186
Article info
Publication history
Published online: October 09, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
